Ionizing irradiation is widely applied as a fundamental therapeutic treatment in several diseases. Acute kidney injury (AKI) represents a global public health problem with major morbidity and mortality. Renal ischemia/reperfusion (I/R) is the main cause of AKI. I/R injury occurs when blood flow to the kidney is transiently interrupted and then restored. Such an ischemic insult significantly impairs renal function in the short and long terms. Renal ischemic preconditioning (IPC) corresponds to the maneuvers intended to prevent or attenuate the ischemic damage. In murine models, irradiation-induced preconditioning (IP) renders the renal parenchyma resistant to subsequent damage by activating defense pathways involved in oxidative stress, angiogenesis, and inflammation. Before envisioning translational applications in patients, safe irradiation modalities, including timing, dosage, and fractionation, need to be defined.
Background: Normothermic Machine Perfusion (NMP) is essential in renal transplantation to improve organ viability before transplantation. This study presents a proof of concept for simultaneous ex situ perfusion of paired porcine kidneys using exogenous creatinine and iohexol clearances to assess renal function, with the primary objective of examining intra‐individual differences. Methods: Five kidney pairs ( n = 10) were harvested from pigs, preserved at 4°C for 3 h, and subjected to 6‐h NMP. Each pair was perfused with a solution containing red blood cells, and perfusion parameters were monitored continuously. Biochemical parameters were assessed using hourly perfusate and urine samples. Kidney function was evaluated using creatinine, which was introduced during the priming procedure. Results: No significant differences were observed between paired kidneys in terms of perfusion and biochemical parameters. Both kidneys maintained stable mean arterial pressures (67.40 ± 12.08 mmHg for right vs. 71.50 ± 4.36 mmHg for left) and flows (68.90 ± 38.61 mL/min vs. 54.00 ± 26.08 mL/min), with consistent electrolyte balance and pH levels. The high inter‐individual variability in perfusion and biochemical parameters underscores the importance of paired comparisons. Conclusions: This pig model of simultaneous NMP of paired kidneys demonstrates that the intra‐individual variance is low, which makes it possible to test treatments prior to kidney transplantation using one kidney as a valid comparator of the other.
1 July 2025 in American Journal of Physiology-Renal Physiology
Kidney transplantation outcomes are influenced by donor type. Brain death has been associated with significant kidney injury, with long-term sequelae. We established two rat models mimicking human conditions of kidney donation after brain death or circulatory arrest. We identified TNFα as the main driver of BD-induced kidney injury, as validated in human pretransplant biopsies. Notably, kidney denervation before BD failed to prevent TNFα-mediated damage. Targeting TNFα signaling in DBD donors may improve transplant outcomes.
27 June 2026 in American Journal of Physiology-Renal Physiology
Brain death (BD) induces a robust inflammatory response that impairs kidney quality before transplantation. Given that TNFα is a central upstream mediator of BD-related injury, we investigated whether selective TNFα inhibition using etanercept could mitigate renal damage in a rat model of BD. BD was maintained for 6 hours in anesthetized rats (n=6 controls; n=12 etanercept-treated; balanced for sex), after which animals were randomized to receive either etanercept (ETNCPT) or vehicle (CTL). We evaluated serum biomarkers, histological kidney injury, immune cell infiltration, and whole-kidney transcriptomic profiles. Etanercept significantly reduced circulating TNFα levels (15.25[12.30-21.05] vs. 34.23[26.03-50.19] pg/mL; p<0.001), while other cytokines remained unchanged. Kidney function parameters (serum creatinine, BUN), electrolytes, and hemodynamics were similar accross groups. In contrast, etanercept markedly attenuated renal injury, reducing acute tubular necrosis (30.0 [15.0–35.0]% vs. 42.5 [40.0–51.3]%; p<0.001), CD11b⁺ myeloid infiltration (0.13 [0.11–0.15]% vs. 0.21 [0.19–0.27]%; p<0.001), tubular KIM-1 expression (0.04 [0.01–0.08]% vs. 0.17 [0.13–0.18]%; p<0.001), and apoptosis (−69%; p=0.036). Transcriptomic analysis identified 281 differentially expressed genes after TNFα blockade, with strong inhibition of inflammatory and apoptotic pathways including TNF signaling, TNFR1/TNFR2 activation, death receptor signaling, and cytokine storm signaling. Predicted downstream effects included reduced kidney cell death and inflammation. Sex-stratified analyses showed similar directional effects in males and females. In summary, early TNFα blockade after BD selectively neutralizes TNFα, limits immune recruitment, and suppresses injury and inflammatory signaling at cellular and transcriptomic levels. Targeting TNFα during kidney donor management may offer a promising strategy to improve kidney quality before transplantation.